These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 2662999)

  • 1. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
    Robertson B
    Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of artificial surfactant (ALEC) in the prophylaxis of neonatal respiratory distress syndrome.
    Morley CJ
    Eur Respir J Suppl; 1989 Mar; 3():81s-86s. PubMed ID: 2663001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant replacement in the management of the neonatal respiratory distress syndrome.
    Robertson B
    Eur J Respir Dis Suppl; 1987; 153():242-8. PubMed ID: 3322864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic treatment of very premature infants with human surfactant.
    Merritt TA; Hallman M; Bloom BT; Berry C; Benirschke K; Sahn D; Key T; Edwards D; Jarvenpaa AL; Pohjavuori M
    N Engl J Med; 1986 Sep; 315(13):785-90. PubMed ID: 3528853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant and respiratory distress syndrome.
    Milner AD
    Turk J Pediatr; 1996; 38(1):37-43. PubMed ID: 8819619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome.
    Reynolds MS; Wallander KA
    Clin Pharm; 1989 Aug; 8(8):559-76. PubMed ID: 2670398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does prophylactic use of bovine surfactant change drug utilization in very premature infants during neonatal period?
    Gortner L; Bernsau U; Hellwege HH; Hieronimi G; Jorch G; Reiter HL
    Dev Pharmacol Ther; 1991; 16(1):1-6. PubMed ID: 1879246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.
    Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of surfactants in 2009.
    Sweet DG; Halliday HL
    Arch Dis Child Educ Pract Ed; 2009 Jun; 94(3):78-83. PubMed ID: 19460896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant replacement therapy at birth: final analysis of a clinical trial and comparisons with similar trials.
    Kendig JW; Notter RH; Cox C; Aschner JL; Benn S; Bernstein RM; Hendricks-Munoz K; Maniscalco WM; Metlay LA; Phelps DL
    Pediatrics; 1988 Nov; 82(5):756-62. PubMed ID: 3054783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversies: synthetic or natural surfactant treatment for respiratory distress syndrome? The case for synthetic surfactant.
    Whitelaw A
    J Perinat Med; 1996; 24(5):427-35. PubMed ID: 8950722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study].
    Shinwell ES; Zmora E; Leven D; Berger I; Karplus M
    Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive approach to the prevention of bronchopulmonary dysplasia.
    Kugelman A; Durand M
    Pediatr Pulmonol; 2011 Dec; 46(12):1153-65. PubMed ID: 21815280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial reconstituted pulmonary surfactant in prevention and treatment of respiratory distress syndrome in neonates.
    Jiang ZQ; Sun GM; Ma YM
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):182-4. PubMed ID: 10072978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods.
    Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous surfactant therapy: newer developments.
    Lacaze-Masmonteil T
    Semin Neonatol; 2003 Dec; 8(6):433-40. PubMed ID: 15001115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of respiratory distress syndrome in premature infants with pulmonary surfactant].
    Gortner L
    Klin Padiatr; 1989; 201(6):417-24. PubMed ID: 2689769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant replacement in preterm infants with respiratory distress syndrome.
    Dani C
    Acta Biomed; 2012; 83 Suppl 1():17-20. PubMed ID: 23029871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
    Dechant KL; Faulds D
    Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting responses of infants with respiratory distress syndrome to exogenous surfactant therapy.
    Ho NK
    Singapore Med J; 1993 Feb; 34(1):74-7. PubMed ID: 8266136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.